Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Foresite Capital Management VI LLC
Form 13F · Q2 2026

Foresite Capital Management VI LLC

CIK 2013341Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$643M
Reported book value
23
Positions
7
Quarters on record
Top 50
Positions

Foresite Capital Management VI LLC — holdings

Top 23 positions of 23, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1CGON Cg Oncology Inc2.4M+6.7%$168M26.2%
2ALMS Alumis Inc4.2M+0.0%$120M18.6%
3SPTX Seaport Therapeutics Inc1.8M—$39M6.0%
4DNLI Denali Therapeutics Inc1.4M+15.4%$36M5.6%
5CLDX Celldex Therapeutics Inc New879,713+178.5%$33M5.1%
6AGIO Agios Pharmaceuticals Inc785,000+49.5%$29M4.5%
7CRVS Corvus Pharmaceuticals Inc1.8M+0.0%$27M4.3%
8PBLS Parabilis Medicines Inc999,044—$27M4.3%
9GHRS Gh Research Plc940,493+198.1%$25M3.9%
10JBIO Jade Biosciences Inc886,667+177.1%$20M3.1%
11HNGE Hinge Health Inc220,400+0.0%$18M2.8%
12KYMR Kymera Therapeutics Inc146,332+0.0%$17M2.6%
13ATAIBECKLEY INC Ataibeckley Inc2.8M+0.0%$14M2.3%
14VSTM Verastem Inc3.1M+0.0%$12M1.9%
15BEAM Beam Therapeutics Inc330,000—$11M1.8%
16NERV Minerva Neurosciences Inc2.0M−0.1%$11M1.7%
17AVBP Arrivent Biopharma Inc301,341—$10M1.6%
18AURA Aura Biosciences Inc1.3M—$9M1.5%
19CRINETICS PHARMACEUTICALS IN Crinetics Pharmaceuticals In212,010+0.0%$8M1.2%
20RACC Research Alliance Corp Iii300,000—$3M0.5%
21ZURA Zura Bio Ltd450,000+0.0%$3M0.4%
22KLRA Kailera Therapeutics Inc37,500—$826,1250.1%
23IRON Disc Medicine Inc970—$70,9460.0%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.